Table 2.

Univariable Analysis of Iatrogenic Risk Factors Associated With HTLV-1 Infection

Risk FactorNo. (%)nHTLV-1Prevalence, %OR (95% CI)P Value
Total3400 (100)361.1
History of hospitalization and surgery
ȃNever hospitalized1282 (38)60.51.009**
ȃHospitalization without surgery1463 (43)181.22.7 (1.1–6.7)
ȃHospitalization with history of surgery453 (13)112.45.3 (2.0–14.4)
ȃHospitalization, history of surgery unknown196 (6)10.51.1 (.1–9.1)
ȃHospitalization unknown6 (0.2)00
Number of hospitalizations
ȃ01284 (38)60.51.04*
ȃ11011 (30)181.83.9 (1.5–9.8)
ȃ2–4681 (20)81.22.5 (.9–7.3)
ȃ≥5321 (9)41.22.7 (.8–9.6)
ȃNA103 (3)00
Number of surgeries
ȃ02746 (81)240.91.04*
ȃ1371 (11)92.42.8 (1.3–6.1)
ȃ284 (2)11.21.4 (.2–10.2)
ȃ3–427 (1)13.74.4 (.6–33.5)
ȃNA172 (5)11
Surgery
ȃHernia308 (9)82.62.9 (1.3–6.4).007**
ȃGyneco-obstetric128 (4)21.61.3 (.3–5.5).75
ȃOthera44 (1)24.54.6 (1.1–19.6).02*
ȃNot specified10 (0.3)00
Transfusion
ȃNo3269 (96)3311.09
ȃYes112 (3)32.72.7 (.8–9.0)
ȃUnknown19 (1)00
Number of blood pouches
ȃ03269 (97)3311.001***
ȃ133 (1)00
ȃ2–439 (1)37.78.2 (2.4–27.9)
ȃUnknown40 (1)00
Scarification
ȃNo759 (22)50.71.24
ȃYes2608 (77)301.21.8 (.7–4.5)
ȃUnknown33 (1)13.0
Risk FactorNo. (%)nHTLV-1Prevalence, %OR (95% CI)P Value
Total3400 (100)361.1
History of hospitalization and surgery
ȃNever hospitalized1282 (38)60.51.009**
ȃHospitalization without surgery1463 (43)181.22.7 (1.1–6.7)
ȃHospitalization with history of surgery453 (13)112.45.3 (2.0–14.4)
ȃHospitalization, history of surgery unknown196 (6)10.51.1 (.1–9.1)
ȃHospitalization unknown6 (0.2)00
Number of hospitalizations
ȃ01284 (38)60.51.04*
ȃ11011 (30)181.83.9 (1.5–9.8)
ȃ2–4681 (20)81.22.5 (.9–7.3)
ȃ≥5321 (9)41.22.7 (.8–9.6)
ȃNA103 (3)00
Number of surgeries
ȃ02746 (81)240.91.04*
ȃ1371 (11)92.42.8 (1.3–6.1)
ȃ284 (2)11.21.4 (.2–10.2)
ȃ3–427 (1)13.74.4 (.6–33.5)
ȃNA172 (5)11
Surgery
ȃHernia308 (9)82.62.9 (1.3–6.4).007**
ȃGyneco-obstetric128 (4)21.61.3 (.3–5.5).75
ȃOthera44 (1)24.54.6 (1.1–19.6).02*
ȃNot specified10 (0.3)00
Transfusion
ȃNo3269 (96)3311.09
ȃYes112 (3)32.72.7 (.8–9.0)
ȃUnknown19 (1)00
Number of blood pouches
ȃ03269 (97)3311.001***
ȃ133 (1)00
ȃ2–439 (1)37.78.2 (2.4–27.9)
ȃUnknown40 (1)00
Scarification
ȃNo759 (22)50.71.24
ȃYes2608 (77)301.21.8 (.7–4.5)
ȃUnknown33 (1)13.0

Abbreviations: CI, confidence interval; HTLV-1, human T-cell leukemia virus; NA, not available; nHTLV-1, number of infected individuals; OR, odds ratio. *P < .05; **P < .01; ***P < .001.

Others surgery included road accident, abdominal, urological surgery (appendicitis), abscesses.

Table 2.

Univariable Analysis of Iatrogenic Risk Factors Associated With HTLV-1 Infection

Risk FactorNo. (%)nHTLV-1Prevalence, %OR (95% CI)P Value
Total3400 (100)361.1
History of hospitalization and surgery
ȃNever hospitalized1282 (38)60.51.009**
ȃHospitalization without surgery1463 (43)181.22.7 (1.1–6.7)
ȃHospitalization with history of surgery453 (13)112.45.3 (2.0–14.4)
ȃHospitalization, history of surgery unknown196 (6)10.51.1 (.1–9.1)
ȃHospitalization unknown6 (0.2)00
Number of hospitalizations
ȃ01284 (38)60.51.04*
ȃ11011 (30)181.83.9 (1.5–9.8)
ȃ2–4681 (20)81.22.5 (.9–7.3)
ȃ≥5321 (9)41.22.7 (.8–9.6)
ȃNA103 (3)00
Number of surgeries
ȃ02746 (81)240.91.04*
ȃ1371 (11)92.42.8 (1.3–6.1)
ȃ284 (2)11.21.4 (.2–10.2)
ȃ3–427 (1)13.74.4 (.6–33.5)
ȃNA172 (5)11
Surgery
ȃHernia308 (9)82.62.9 (1.3–6.4).007**
ȃGyneco-obstetric128 (4)21.61.3 (.3–5.5).75
ȃOthera44 (1)24.54.6 (1.1–19.6).02*
ȃNot specified10 (0.3)00
Transfusion
ȃNo3269 (96)3311.09
ȃYes112 (3)32.72.7 (.8–9.0)
ȃUnknown19 (1)00
Number of blood pouches
ȃ03269 (97)3311.001***
ȃ133 (1)00
ȃ2–439 (1)37.78.2 (2.4–27.9)
ȃUnknown40 (1)00
Scarification
ȃNo759 (22)50.71.24
ȃYes2608 (77)301.21.8 (.7–4.5)
ȃUnknown33 (1)13.0
Risk FactorNo. (%)nHTLV-1Prevalence, %OR (95% CI)P Value
Total3400 (100)361.1
History of hospitalization and surgery
ȃNever hospitalized1282 (38)60.51.009**
ȃHospitalization without surgery1463 (43)181.22.7 (1.1–6.7)
ȃHospitalization with history of surgery453 (13)112.45.3 (2.0–14.4)
ȃHospitalization, history of surgery unknown196 (6)10.51.1 (.1–9.1)
ȃHospitalization unknown6 (0.2)00
Number of hospitalizations
ȃ01284 (38)60.51.04*
ȃ11011 (30)181.83.9 (1.5–9.8)
ȃ2–4681 (20)81.22.5 (.9–7.3)
ȃ≥5321 (9)41.22.7 (.8–9.6)
ȃNA103 (3)00
Number of surgeries
ȃ02746 (81)240.91.04*
ȃ1371 (11)92.42.8 (1.3–6.1)
ȃ284 (2)11.21.4 (.2–10.2)
ȃ3–427 (1)13.74.4 (.6–33.5)
ȃNA172 (5)11
Surgery
ȃHernia308 (9)82.62.9 (1.3–6.4).007**
ȃGyneco-obstetric128 (4)21.61.3 (.3–5.5).75
ȃOthera44 (1)24.54.6 (1.1–19.6).02*
ȃNot specified10 (0.3)00
Transfusion
ȃNo3269 (96)3311.09
ȃYes112 (3)32.72.7 (.8–9.0)
ȃUnknown19 (1)00
Number of blood pouches
ȃ03269 (97)3311.001***
ȃ133 (1)00
ȃ2–439 (1)37.78.2 (2.4–27.9)
ȃUnknown40 (1)00
Scarification
ȃNo759 (22)50.71.24
ȃYes2608 (77)301.21.8 (.7–4.5)
ȃUnknown33 (1)13.0

Abbreviations: CI, confidence interval; HTLV-1, human T-cell leukemia virus; NA, not available; nHTLV-1, number of infected individuals; OR, odds ratio. *P < .05; **P < .01; ***P < .001.

Others surgery included road accident, abdominal, urological surgery (appendicitis), abscesses.

Close
This Feature Is Available To Subscribers Only

Sign In or Create an Account

Close

This PDF is available to Subscribers Only

View Article Abstract & Purchase Options

For full access to this pdf, sign in to an existing account, or purchase an annual subscription.

Close